Time-Cap Labs Recalls Kroger Brand Aspirin and Ibuprofen Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

What was recalled

On June 16, 2022, the U.S. Consumer Product Safety Commission (CPSC) announced a significant recall involving two specific over-the-counter medication products sold under the Kroger brand. This action was taken by Time-Cap Labs, the manufacturer responsible for producing these items, due to a critical safety oversight regarding their packaging. It is important to understand exactly which products are affected, as this recall does not apply to all Kroger medications, but rather to two distinct bottle types that failed to meet federal safety standards. The first product involved is the Kroger Low Dose Aspirin. Specifically, this is the 81 mg Delayed-Release Tablet formulation, packaged in a substantial container holding 300 enteric-coated tablets. Visually, you can identify this specific recall lot by its distinctive green and yellow label. The bottle itself features a green continuous thread gear closure, which is the cap mechanism designed to secure the contents.

The second product caught in this recall is the Kroger Ibuprofen. This particular item is formulated as 200 mg Pain Reliever and Fever Reducer capsules, contained within a bottle of 160 softgels. To distinguish this bottle from others on the shelf, look for the blue and white label design and the corresponding blue continuous thread gear closure cap. These visual cues—the specific color schemes of the labels and the matching colored caps—are key identifiers for consumers trying to determine if their current supply is part of this batch.

While the official recall notice provides detailed lot numbers and Universal Product Codes (UPCs) for precise identification, the core issue lies in the construction of these bottles. The products were distributed through Kroger retail locations, but the critical factor is not just where they were bought, but that they were sold without the mandatory safety features required by law. The recall encompasses specific UPC codes 4126001295 for the aspirin and 4126001298 for the ibuprofen, along with a wide variety of lot numbers such as A077J, F032H, J011H for the aspirin, and FH1163, C11044, C11047 among others for the ibuprofen. If you have these bottles in your medicine cabinet, they are part of this specific safety alert.

The hazard, explained

At the heart of this recall is a critical failure in safety design: the packaging does not meet the mandatory standards for child-resistant closures. Under the Poison Prevention Packaging Act (PPPA), the U.S. Consumer Product Safety Commission requires that certain over-the-counter drugs, including aspirin and ibuprofen, be sold in special containers that are difficult for children under five years old to open. The Kroger brand products involved in this recall lack these essential protective features. While the bottles may appear sturdy and sealed from the outside, the "continuous thread gear closure" on both the green-labeled aspirin and blue-labeled ibuprofen bottles does not provide the necessary resistance or complexity required to prevent a young child from twisting it open.

This is not merely an inconvenience; it creates a direct pathway for accidental ingestion. Young children are naturally curious explorers who learn about their world by putting objects in their mouths. Without a child-resistant mechanism, a toddler can easily remove the cap and access the medication inside. The danger lies in the potency of the substances contained within. Aspirin (acetylsalicylic acid) and ibuprofen are nonsteroidal anti-inflammatory drugs (NSAIDs). While these medications are safe and effective for adults when taken as directed, they can be highly toxic to small children even in very small doses.

When a child ingests these drugs, the effects can be severe and rapid. Aspirin poisoning, in particular, can lead to a dangerous condition called salicylate toxicity, which disrupts the body's ability to regulate temperature, breathing, and blood sugar levels. Symptoms may include ringing in the ears, rapid breathing, vomiting, confusion, and in severe cases, seizures or coma. Ibuprofen overdose can cause similar symptoms, including abdominal pain, nausea, drowsiness, and kidney damage. Because children have lower body weights and developing metabolic systems, they are far more vulnerable to these toxic effects than adults.

The risk is compounded by the fact that these medications often come in forms that might look appealing or tasteable to a child. The recalled items include delayed-release aspirin tablets and softgel ibuprofen capsules. Softgels, in particular, can be mistaken for candy due to their smooth texture and potential sweetness. The absence of child-resistant packaging means there is no physical barrier to stop a determined child from accessing these pills. This recall highlights how a simple mechanical failure in the bottle cap transforms a common household medicine into an immediate poisoning hazard, underscoring why regulatory standards for packaging are not just bureaucratic red tape but vital life-saving measures.

Who is most at risk

The primary group at immediate and severe risk in this specific recall consists of young children, particularly those under the age of five. The core issue here is not that aspirin or ibuprofen are inherently dangerous substances when used correctly; rather, it is the combination of their toxicity to small bodies and the failure of the safety mechanism designed to keep them away from curious hands. According to the U.S. Consumer Product Safety Commission (CPSC), these Kroger brand products were shipped without child-resistant packaging, which is a legal requirement under the Poison Prevention Packaging Act (PPPA). This act exists for a very specific reason: standard plastic caps can be easily opened by toddlers who are developing their fine motor skills and dexterity. While adults may struggle with "push-and-turn" safety caps due to arthritis or reduced grip strength, young children often find these mechanisms surprisingly easy to bypass. Without the specialized, difficult-to-open child-resistant closures that should have been on these bottles, a toddler can access the medication in seconds, turning a harmless-looking bottle into a vector for accidental poisoning.

We must also consider the vulnerability of individuals living in households with multiple generations, such as grandparents caring for grandchildren or families sharing medications. In these environments, the risk is compounded by familiarity and convenience. When over-the-counter drugs are kept in easily accessible places like bathroom cabinets, nightstands, or kitchen counters without proper safety locks, the barrier to entry for a child drops significantly. The recalled Kroger aspirin (81 mg delayed-release tablets) and ibuprofen (200 mg softgels) look like any other household item. A child might mistake the bright green and yellow label of the aspirin or the blue and white label of the ibuprofen for candy, especially since the pills themselves are small and swallowable. The absence of the required child-resistant closure means there is no physical deterrent to prevent a young person from opening the bottle and consuming multiple doses at once.

Elderly individuals, while not the primary target of child-safety regulations, also face indirect risks in this scenario. Many older adults manage chronic pain or fever conditions using these very medications. If they are accustomed to the ease of non-child-resistant caps due to physical limitations like arthritis, they might inadvertently leave bottles open or accessible after use, creating a hazard for any children in the home. Furthermore, if an elderly person has cognitive decline or memory issues, they might forget whether they have taken their dose and consume more, though this is a general medication risk rather than one specific to this recall's packaging failure. However, the most acute danger remains with young explorers who lack the judgment to understand that these pills are powerful drugs, not treats. For them, even a small amount of aspirin or ibuprofen can lead to serious health complications, including stomach bleeding, kidney damage, or more severe systemic poisoning, making the presence of these specific unlabeled, non-compliant bottles in a home with young children a critical safety emergency.

How to tell if you have the recalled item

Identifying whether your over-the-counter medications are part of this specific recall requires a careful look at two distinct products: Kroger Brand Aspirin and Kroger Brand Ibuprofen. Because these items are sold under the Kroger label, they may look very similar to other bottles in your medicine cabinet or pantry. To be certain you have not purchased an affected unit, you must inspect both the bottle’s physical characteristics and the specific identification numbers printed on the label.

First, locate the Aspirin product. You are looking for a bottle with a distinctive green and yellow label. The text on the front should clearly state "Kroger, Low Dose, Aspirin, 81 mg Delayed-Release Tablets / Pain Reliever." It is crucial to verify the quantity; this recall applies specifically to bottles containing 300 enteric-coated tablets. Additionally, check the cap of the bottle. The affected Aspirin bottles feature a green continuous thread gear closure. If your bottle has a different color cap or a standard twist-off lid without that specific gear mechanism, it is likely not part of this recall.

Next, examine any Ibuprofen products you own. The recalled version will have a blue and white label. Look for the text "Kroger, Ibuprofen, Capsules, 200 mg Pain Reliever / Fever Reducer." Note that while the label says "Capsules," the description also mentions "160 softgels," so be sure to count the contents if possible, though the UPC code is the definitive identifier. The bottle closure for this product is a blue continuous thread gear closure. If your Ibuprofen bottle has a different colored cap or lacks the specific blue gear closure, it is safe from this particular recall.

The most reliable way to confirm if your bottle is included in this recall is by checking the Universal Product Code (UPC) and the Lot number. These codes are found on the back of the bottle label. Please compare the numbers on your bottle against the following list:

• For Aspirin: The UPC must be 4126001295. The lot numbers included in the recall are A077J, F032H, F035H, J011H, and K031H.
• For Ibuprofen: The UPC must be 4126001298. The lot numbers included in the recall are FH1163, C11044, C11047, C11064, C11065, C11079, and C11084.

If your UPC or Lot number does not match these exact codes, your product is not part of this recall. However, if you have any doubt, it is always safer to assume the product might be affected until you can verify the numbers directly with Kroger’s customer service or their official recall website.

What to do — step by step

Your refund, repair, or replacement options

When you encounter a product recall, the most pressing question is often, "What happens next?" and "How do I get my money back?" In this specific case involving Kroger brand aspirin and ibuprofen, the remedy provided by Time-Cap Labs and the Consumer Product Safety Commission (CPSC) is straightforward and consumer-friendly. There is no need to worry about complex repair processes or waiting for replacement units of defective packaging. Instead, the primary option offered is a full refund. This approach is standard for recalls involving over-the-counter medications where the defect relates to safety packaging rather than the efficacy of the drug itself. Because the issue is that the bottles are not child-resistant, the products themselves cannot simply be repackaged and resold as safe alternatives. Therefore, the only viable path for consumers who have purchased these items is to dispose of them safely and receive their money back.

To initiate this process, you must contact Kroger directly. The recall notice provides specific instructions on how to reach their customer service team to arrange your refund. You can call them at 800-576-4377, which is also listed as 800-KRO-GERS for easier dialing. It is important to note the hours of operation when you plan to call, as availability varies by day. From Monday through Friday, you can reach them from 7 a.m. to 12 a.m. (midnight) Eastern Time. On weekends, their hours are slightly different: they are available from 7 a.m. to 9:30 p.m. Eastern Time on both Saturday and Sunday. If calling is not convenient for you, or if you prefer to handle things online, there are digital options available as well.

You can visit www.kroger.com/i/recall-alerts directly to find more information about the recall process. Alternatively, if you are already browsing Kroger’s main website at www.kroger.com, look for the "Recall Alerts" link located at the bottom of the page. Clicking this will guide you through the necessary steps. Additionally, Time-Cap Labs, the manufacturer behind this recall, has set up a dedicated section on their website. By visiting www.timecaplabs.com and clicking on "SAFETY RECALL" at the top of the page, you can access further details. While these online resources provide important context, the actual refund transaction is managed through Kroger’s customer service channels.

Before you contact them to claim your refund, remember that you must first ensure the product is stored safely. The remedy includes immediate instructions to store the recalled products in a location completely out of reach and sight of children. This step is critical not just for safety, but also because proper disposal is part of the process. When you speak with Kroger, they will inform you on how to properly dispose of the product to ensure it does not pose any further risk to your household or the environment after you have been refunded. Do not attempt to use the product again; the goal is to remove it from your home entirely and restore your financial position by receiving a full refund for the purchase price.

What can happen if you ignore it

It is completely natural to feel hesitant about discarding a bottle of medicine, especially when it appears perfectly intact and has been sitting quietly on your shelf. You might think that as long as the pills look normal and the expiration date hasn’t passed, they are safe to keep using. However, ignoring this specific recall creates a serious, silent danger that is not about the quality of the medication itself, but entirely about how easily it can be accessed by those who should never touch it. The core issue here is the absence of child-resistant packaging. Under federal law, over-the-counter products containing aspirin and ibuprofen must be sealed in special containers that are difficult for young children to open. Because these Kroger brand bottles lack that critical safety feature, they offer no physical barrier to a curious toddler or a young child who has learned to climb or reach for items on lower shelves.

If this product is left in its current packaging, the consequences of an accidental ingestion can be severe and potentially life-threatening. Aspirin and ibuprofen are powerful nonsteroidal anti-inflammatory drugs (NSAIDs) and analgesics. While safe for adults when taken as directed, even a small number of tablets or softgels can cause acute poisoning in a small child. Young bodies process these chemicals differently and at much lower thresholds than adults. Ingesting aspirin can lead to salicylate toxicity, which may result in rapid breathing, confusion, seizures, and metabolic disturbances that require immediate emergency medical intervention. Similarly, an ibuprofen overdose can damage the kidneys, cause stomach bleeding, or lead to central nervous system depression. The danger is compounded by the fact that children are often attracted to the colors of the bottles—the green and yellow for aspirin, the blue and white for ibuprofen—or the familiar shape of the pill containers, making them more likely to investigate them as toys.

While the Consumer Product Safety Commission (CPSC) reports no incidents or injuries have been recorded from this specific batch so far, that absence of data does not mean the risk is absent. It only means that, fortunately, no one has yet opened one of these non-compliant bottles and swallowed the contents. However, the potential for tragedy exists in every home where these bottles remain unsecured. The "failure to meet child-resistant packaging requirement" is not a minor bureaucratic oversight; it is a fundamental safety gap. By continuing to use these products without taking action, you are leaving a highly toxic substance within easy reach of your most vulnerable family members. The risk is not theoretical; it is a direct consequence of removing the mandatory safeguard designed specifically to prevent accidental poisoning. Ignoring the recall means accepting that any child who can manipulate the bottle cap has immediate access to a dose of medication that could land them in the hospital or worse.

Staying safe: broader tips

While specific product recalls are essential for addressing immediate hazards, building a robust safety culture in your home requires looking at the bigger picture. Over-the-counter medications, like the aspirin and ibuprofen involved in this recent notice, are among the most common causes of pediatric poisoning because they often look appealing to young children. They may be sweet-tasting or brightly colored, and they are frequently stored in plain sight where curiosity gets the better of judgment. To protect your family, you must treat every medication with the same respect as a hazardous chemical.

The most critical step is always proper storage. Never rely on "child-resistant" caps alone. These closures are designed to be difficult for children under five to open, but they are not foolproof proof-proof. A determined toddler can often figure them out given enough time. Instead, store all medicines in a high, locked cabinet or a secure box that is completely out of reach and out of sight. The key should be kept somewhere you do not normally go, such as a workplace or a friend’s house, so that a child cannot access it even if they find the medicine bottle. This physical barrier is your first line of defense.

Equally important is the habit of immediate disposal. When you finish a course of medication, do not leave empty bottles or partially full containers lying around for weeks. Dispose of them promptly according to local guidelines. Many pharmacies and police stations offer drug take-back programs where you can drop off unused medicines safely. If you must throw them away, mix the pills with an unpalatable substance like dirt, cat litter, or used coffee grounds in a sealed bag before trashing them. This prevents anyone from retrieving them from the garbage. Never flush medications down the toilet unless the label specifically instructs you to do so, as this can contaminate local water supplies.

Finally, make it a routine to check for recalls regularly. You might assume that products on your shelves are always safe, but manufacturers and government agencies like the Consumer Product Safety Commission (CPSC) frequently issue alerts due to manufacturing errors or packaging defects. Sign up for email notifications from the CPSC and other relevant agencies. This proactive approach ensures that you are never caught off guard by a hidden defect. By combining vigilant storage habits with regular safety checks, you create an environment where accidents are far less likely to happen, giving you peace of mind every day.